Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07577401 · ClinicalTrials.gov registry record · NA
Calming Minds Study
A NA study, sponsored by University of California, Los Angeles.
- Not yet
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT07577401: Clinical Trial NA study, sponsored by University of California, Los Angeles.
NCT07577401 is a NA study that has not yet begun recruiting, run by University of California, Los Angeles. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07577401, a NA study, has not yet begun recruiting, sponsored by University of California, Los Angeles.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
The goal of this study is to understand why certain treatments help people reduce repetitive negative thinking (RNT), which is common in many mental health problems. We want to: 1. Figure out what actually causes repetitive negative thinking to decrease when people use cognitive-behavioral therapy (CBT). 2. Find out which parts of RNT-focused CBT are the most important - the parts that truly make a difference in reducing RNT. The main result we will look at is how much a person's repetitive negative thought patterns change from the start of the study to the end of treatment (16 weeks). We will measure this using the Perseverative Thinking Questionnaire at baseline and week 16.
Primary Outcome
Change in repetitive negative thought as indexed by the Perseverative Thinking questionnaire
Interventions
- BEHAVIORAL Psychoeducation
- BEHAVIORAL Be Specific
- BEHAVIORAL Be Kind
- BEHAVIORAL Be Present
- BEHAVIORAL Break Habit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-06-08 |
| Est. Completion | 2028-06-14 |
| Phase | NA |
What is known before NCT07577401 opens enrollment
NCT07577401 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 5 interventions - of which Psychoeducation is the first listed.
NCT07577401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07577401 about?
NCT07577401 is a clinical study titled "Calming Minds Study". The goal of this study is to understand why certain treatments help people reduce repetitive negative thinking (RNT), which is common in many mental health problems. We want to: 1. Figure out what actually causes repetitive negative thinking to decrease when people use cognitive-behavioral therapy ...
What is the current status of trial NCT07577401?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-06-08. Estimated completion is 2028-06-14.
What interventions are being tested in trial NCT07577401?
The interventions under investigation include: Psychoeducation (BEHAVIORAL), Be Specific (BEHAVIORAL), Be Kind (BEHAVIORAL), Be Present (BEHAVIORAL), Break Habit (BEHAVIORAL).
Who is sponsoring clinical trial NCT07577401?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07577401's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI